All matches

E.C. 72· Female

Partner site Likely eligible
Patient snapshotDe-identified — from your records

Mild cognitive impairment, MMSE 25, family history of Alzheimer's. Followed in clinic.

ConditionEarly Alzheimer's disease
SourceProblem list
Age / sex72 · Female
AI pre-screen Likely eligible 86/100
Meets criteria
MCI with documented memory decline
Age within 55-80 window
Study partner available
To confirm at screening
Amyloid PET / CSF confirmation needed
MRI to rule out microhemorrhages
Clinical picture fits; biomarker confirmation happens at the trial site.
AI-assisted decision support. A qualified team member must review and decide.
Matched study
Anti-Amyloid Infusion in Early Alzheimer's Disease
Sunnybrook Health Sciences Centre · Toronto, ON
NCT05310071
Next step

Refer to the trial site once the patient consents.